WO2005063111A1 - 医療用カプセル装置 - Google Patents
医療用カプセル装置 Download PDFInfo
- Publication number
- WO2005063111A1 WO2005063111A1 PCT/JP2004/018725 JP2004018725W WO2005063111A1 WO 2005063111 A1 WO2005063111 A1 WO 2005063111A1 JP 2004018725 W JP2004018725 W JP 2004018725W WO 2005063111 A1 WO2005063111 A1 WO 2005063111A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- unit
- medicine
- magnetic force
- capsule device
- body cavity
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/04—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor combined with photographic or television appliances
- A61B1/041—Capsule endoscopes for imaging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
- A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
Definitions
- the present invention includes a medical capsule device, more specifically, an observation means for observing the state of a body cavity or the like inside a substantially capsule-shaped casing as a whole, and can observe a desired site in a body cavity or the like.
- the present invention relates to a medical capsule device capable of spraying medicines and the like.
- a tubular insertion portion having an imaging element or the like at a distal end, an operation portion connected to the insertion portion, and an image connected to the operation portion
- Processing device ⁇
- Display device ⁇ Consists of various devices such as a light source device, and is configured so that the insertion section can be inserted into the body cavity from the subject's oral cavity or the like to observe a desired site in the body cavity.
- Endoscope devices have been put to practical use and are widely used. In such a conventional endoscope apparatus, there are restrictions on the length of an insertion portion to be inserted into a body cavity, and therefore, there are restrictions on the range in which observation, inspection, and the like can be performed.
- a small-sized endoscope containing, for example, an imaging unit (observing unit) including an imaging optical system, a lighting unit, a communication unit and a power receiving unit or a power supply inside a capsule-shaped casing
- an imaging unit observing unit
- a lighting unit including an imaging optical system
- a communication unit including an imaging optical system
- a power receiving unit or a power supply inside a capsule-shaped casing
- a conventional medical capsule device is configured in a form in which a drug or the like is stored inside the capsule, and after the subject swallows the capsule device, the capsule device is inserted into the body cavity.
- Japanese Patent Application Laid-Open No. 19140/1990 discloses a configuration in which a drug or the like contained in a capsule can be released to the outside of the capsule at any time by driving means such as electric control.
- the medical capsule device disclosed in the above-mentioned Japanese Patent Application Laid-Open No. 2-19140 uses a mechanochemical substance that expands and increases in volume in response to a change in pH value or the application of voltage. Releases the drug and the like stored inside the capsule to the outside of the capsule It is configured as follows.
- the position of the lesion is determined. It is convenient if it is possible to carry out a predetermined treatment such as spraying a medicine.
- the medicine that can be sprayed may be, for example, a medicine for treatment, or a marking agent or the like for specifying the diseased part.
- the medical capsule device observes the inside of the body cavity at the same time as performing a medical treatment of a desired site, or performs a normal endoscope or the like performed after the medical capsule device performs an inspection.
- a medical treatment of a desired site or performs a normal endoscope or the like performed after the medical capsule device performs an inspection.
- the present invention has been made in view of the above points, and an object of the present invention is to provide an observation means for observing the inside of a body cavity and a mechanism for containing and releasing a medicine or the like.
- a medical capsule device provided with a medical device a main unit provided with an observation means for observing the inside of a body cavity and a drug unit provided with a mechanism for containing and releasing a drug or the like are separately formed, and both are easily formed.
- various An object of the present invention is to provide a medical capsule device that has a medicine and can contribute to reduction of management cost.
- a medical capsule device is a medical capsule device to be introduced into a body cavity, a main unit having a function of observing the inside of the body cavity, and a function of containing and releasing a medicine. And a medicine unit having at least one of the following, wherein the main unit and the medicine unit are configured to be freely connected and separated.
- a medical capsule device including an observation unit for observing the inside of a body cavity and a mechanism for containing and releasing a medicine or the like is provided with an observation unit for observing the inside of a body cavity.
- the main body unit and the drug unit equipped with a mechanism for containing and releasing the drug etc. are formed separately, and the two can be easily connected and separated. It is possible to provide a medical capsule device which has the above-mentioned medicine and can contribute to reduction of management cost.
- FIG. 1 is a schematic configuration diagram showing an internal configuration of a medical capsule device according to a first embodiment of the present invention.
- FIG. 2 is a conceptual diagram showing a state where a main unit and a drug unit are separated in the capsule device of FIG. 1.
- FIG. 3 is a conceptual diagram showing a state in which a soluble film is dissolved when a main body unit and a drug unit in the capsule device of FIG. 1 are connected and put into a body cavity.
- FIG. 4 is a conceptual diagram showing a state in which a drug is released from a drug unit by operating a magnetic force generating unit of the main unit in the capsule device of FIG.
- FIG. 5 is a schematic configuration diagram conceptually showing the arrangement of internal components of a medical capsule device according to a second embodiment of the present invention.
- FIG. 6 is a cross-sectional view taken along the line VI-VI of FIG. BEST MODE FOR CARRYING OUT THE INVENTION
- FIG. 1 is a schematic configuration diagram showing an internal configuration of the medical capsule device according to the first embodiment of the present invention.
- the internal configuration of the capsule device is shown by showing a cross section of the capsule device.
- a medical capsule device 1 (hereinafter simply referred to as a capsule device) 1 of the present embodiment includes various constituent members such as observation means for observing the inside of a body cavity, each of which is disposed inside a housing. And a medicine unit 20 having a mechanism capable of containing and releasing the medicine.
- FIG. 1 shows a state in which the main unit 10 and the medicine unit 20 are connected.
- the outer shape is formed so that the whole becomes substantially capsule-shaped.
- an external control device or the like including control means for externally controlling the main unit 10 separately from the units 10 and 20 is omitted. And the system is configured.
- the main unit 10 includes a main unit outer case 11 which is an outer member for sealing the inside of the main unit in a liquid-tight manner, and various components disposed inside the main unit outer case 11.
- an image pickup unit serving as an observation means, including a signal processing unit 16 serving as a signal processing unit for processing an output signal from the solid-state imaging device 14, and the signal processing unit 16, the illumination 13, and an electric drive for controlling the same.
- a wireless transmission / reception unit 17 which is a communication means for transmitting / receiving to / from the device, etc .; a battery 18 for supplying power to electric components of the capsule device 1; and a magnetic force generating unit for performing signal control for generating a magnetic force.
- 19b and a magnetic force control unit 19 that controls the drive of the magnetic force generation unit 19b to control the magnetic force generated from the magnetic force generation unit 19b to control the release operation of the medicine 22.
- a flexible printed circuit board (C) for electrically connecting the circuit board 12, the wireless transmission / reception unit 17, the battery 18, the magnetic force control unit 19a, and the magnetic force generation unit 19b to each other.
- FPC 12a and the like.
- the main unit outer case 11 is formed of, for example, a hard member such as a resin, and covers and protects a front portion of the main unit 10 of the forceps device 1, and at the same time, an illumination light beam or an optical beam emitted from the illumination 13.
- a transparent window portion 11a through which a light beam incident on the lens group 15 can be transmitted, and a main body portion which forms a main part of the main body unit outer case 11 and various internal constituent members are arranged, and covers and protects these from outside. It is composed of l ib.
- the optical lens group 15 among the components of the imaging unit as the observation means is composed of a plurality of lens groups, and the optical lens group 15 is held by the lens barrel 15a.
- a circuit board 12 is provided at a predetermined position on the rear side along the optical axis of the optical lens group 15 held by the lens barrel 15a so as to be substantially orthogonal to the optical axis.
- the solid-state imaging device 14 is mounted and disposed with its light receiving surface facing the front.
- the solid-state imaging device 14 is an imaging device such as a CCD or a CMOS that performs a photoelectric conversion process upon receiving an optical image of a test object formed through the optical lens group 15.
- an electric circuit or the like constituted by a plurality of electric components or the like for driving the solid-state imaging device 14 and performing predetermined signal processing is mounted on the circuit board 12.
- an electric circuit or the like constituted by a plurality of electric components or the like for driving the solid-state imaging device 14 and performing predetermined signal processing is mounted on the circuit board 12.
- the optical image of the subject formed by the optical lens group 15 is formed on the light receiving surface of the solid-state imaging device 14, where a predetermined photoelectric conversion process or the like is performed and a predetermined image signal is generated. Is now being generated.
- the illumination 13 is a light emitting light source such as a light emitting diode (LED) or an organic EL for illuminating a subject such as a digestive organ in a body cavity.
- the illumination 13 is mounted and arranged on the mounting surface of the circuit board 12 so as to illuminate the subject on the front side of the capsule device 1.
- the solid-state imaging device 14 receives the optical image of the subject formed by the optical lens group 15, performs signal processing such as a predetermined photoelectric conversion process, and performs an electrical signal corresponding to the optical image of the subject. (Image signal).
- the image signal output from the solid-state imaging device 14 is subjected to various kinds of signal processing (image signal processing, communication processing, and the like) in the signal processing section 16 and then to the wireless transmission / reception section 17. Output.
- the medicine release control means comprises the magnetic force generation unit 19b and the magnetic force control unit 19a as described above, and constitutes a mechanism for releasing a medicine 22 housed in the medicine unit 20, which will be described later, to the outside.
- the magnetic force control unit 19a receives a predetermined control signal, for example, a predetermined wireless signal from a wireless transmission device provided outside the body cavity, and controls the magnetic force of the magnetic force generation unit 19b based on the signal. (Details will be described later).
- the medicine unit 20 includes a medicine unit outer case 21 formed of a hard member such as a resin and having a space in which the medicine 22 can be filled, and a medicine filled in the medicine unit outer case 21. 22, a magnetic force attracting portion 23 to be attracted by magnetic force, an ejection nozzle 24 for ejecting and ejecting the medicine 22 filled in the medicine unit outer case 21 to the outside, and the ejection nozzle 24, which is constituted by a soluble film 25 or the like which is an injection nozzle opening / closing means provided for closing the hole 21a of the medicine unit outer case 21 and making the inside liquid-tight.
- the medicine 22 used here is, for example, a medicine for treatment, a marking agent for specifying a lesion, or the like.
- the magnetic force attracting portion 23 is formed of a plate-like member capable of attracting magnetic force.
- the magnetic force generating portion 19b generates a magnetic force by the magnetic force controlling portion 19a of the main unit 10, the medicine unit In the inside of 20, it is arranged so as to be able to move in parallel in a direction to be attracted to the magnetic force generating portion 19b.
- the injection nozzle 24 communicates with a hole 21a formed substantially at the center of one side surface of the medicine unit outer case 21 and is disposed toward the inside of the medicine unit outer case 21. It is formed by members.
- the injection nozzle 24 is located outside the medicine unit. It is provided to release the medicine 22 filled in the interior of the packaging case 21 to the outside.
- the magnetic force generation unit 19b moves in parallel to the magnetic force generation unit 19b in a direction in which the magnetic force suction unit 23 of the medicine unit 20 is suctioned. . Then, the medicine 22 filled in the medicine unit 20 is pressed. Accordingly, the medicine 22 is thereby released to the outside of the medicine unit outer case 21 through the injection horn 24.
- the dissolvable film 25 is formed of a thin film-like member formed of a component that dissolves in the body cavity, such as gelatin.
- the present capsule device 1 When the present capsule device 1 is used, that is, in an environment in a body cavity, the soluble film 25 is dissolved. Therefore, when the capsule device 1 releases the medicine 22 when it reaches a desired site in the body cavity, the closed state of the hole 21a of the medicine unit outer case 21 is released, and the medicine 22 is easily released. .
- the main unit 10 and the medicine unit 20, which are configured as described above, are connected by a mechanical connection means such as a screw-in method or a screw.
- a mechanical connection means such as a screw-in method or a screw.
- a male screw is formed on the outer peripheral surface side of one end portion (the side where the magnetic force generating portion 19b is provided) of the main unit outer case 11 of the main unit 10
- a female screw is formed near the other end of the drug unit outer case 21 of the drug unit 20 (the side opposite to the side where the hole 21a is formed), and these are connected by means of a screw connection.
- FIG. 2 is a conceptual diagram showing a state where the main unit 10 and the medicine unit 20 are separated from each other in the present capsule device 1.
- FIG. 3 is a conceptual diagram showing a state in which the soluble film 25 is dissolved when the main unit 10 and the drug unit 20 in the capsule device 1 are connected and put into a body cavity.
- FIG. 4 is a conceptual diagram showing a state in which the magnetic force generating portion 19b of the main unit 10 is operated to release the medicine 22 from the medicine unit 20 in the capsule device 1.
- the 2 to 4 the configuration of the capsule device 1 is illustrated in a simplified manner, and the internal configuration is partially omitted.
- the capsule device 1 before use is in a state where the main unit 10 and the medicine unit 20 are separated as shown in FIG.
- a medicine unit 20 according to the intended use is selected from a plurality of kinds of medicine units 20, and this is mechanically connected to the main unit 10. Then, the state shown in Fig. 1 is obtained.
- the subject swallows the capsule device 1 in a state where both the main unit 10 and the medicine unit 20 are connected. Thereby, the capsule device 1 moves in the body cavity of the subject by the peristaltic motion. At this time, on the side of the main unit 10, the imaging unit is in operation and the state in the body cavity can be observed.
- the capsule device 1 moves inside the body cavity, the inside of the body cavity is illuminated by the illumination 13.
- the optical image in the body cavity is formed on the light receiving surface of the solid-state imaging device 14 by the optical lens group 15.
- the solid-state imaging device 14 receives the optical image, performs photoelectric conversion, generates an electrical signal, and outputs the electrical signal to the signal processing unit 16.
- the signal processing unit 16 performs predetermined signal processing, and outputs the signal to the wireless transmission / reception unit 17.
- the wireless transmitting / receiving unit 17 performs predetermined wireless communication of the input image signal and transmits the image signal to an external control device (not shown).
- the external control device Upon receiving this, the external control device performs predetermined signal processing and outputs the processed signal to, for example, a monitor device (not shown) or a recording device. As a result, an image of the body cavity is displayed on the monitor device, and an image signal representing the image is recorded on the recording device.
- the dissolvable membrane 25 provided in the drug unit 20 of the capsule device 1 is gradually changed in the environment inside the body cavity.
- the dissolution starts and the state shown in Fig. 3 is reached. In this state, the hole 21a of the medicine unit outer case 21 of the medicine unit 20 is opened.
- the operator of the capsule device 1 waits until the capsule device 1 reaches a desired site (lesion or the like) in the body cavity while observing the image in the body cavity displayed by the monitor device. . Then, for example, when the capsule device 1 reaches a desired site in the body cavity, the operator performs a predetermined operation of the external control device and transmits a predetermined control signal to the main unit 10.
- the control signal issued at this time is magnetic control
- This command signal is transmitted to the magnetic force control unit 19a via the wireless transmission / reception unit 17.
- the magnetic force control unit 19a drives and controls the magnetic force generation unit 19b, so that a predetermined magnetic force is generated from the magnetic force generation unit 19b. Then, the magnetic force acts on the magnetic force attracting portion 23 of the medicine unit 20, and the magnetic force attracting portion 23 starts moving in the direction of attracting the magnetic force generating portion 19b (the direction of the arrow X shown in FIG. 3). Accordingly, the medicine 22 filled in the medicine unit outer case 21 is ejected from the hole 21a to the outside through the ejection nozzle 24 as shown in FIG. As a result, the medicine 22 adheres to a desired site such as a lesion in the body cavity of the subject.
- the capsule device 1 continues to move further by peristalsis in the body cavity, and is naturally discharged outside the body.
- the main body unit 10 having the built-in imaging unit and the like capable of observing the inside of the body cavity and the medicine 22 are housed inside and released at any time.
- the medicine unit 20 and the medicine unit 20 are configured by separate members, and the connection between the two is made by an easy means. By simply connecting, a capsule device 1 suitable for each symptom can be constructed, which is extremely convenient.
- a wide variety of medicine units 20 can be prepared according to the kind of medicine 22 to be filled therein.
- the main unit 10 made of relatively expensive components is the same as the medicine unit 20. Since there is no need to prepare the same number, it is possible to contribute to reducing management costs.
- main unit 10 can be reused, it is possible to further contribute to a reduction in management cost.
- the drug unit 20 since the configuration of the drug unit 20 can be simplified and the drug unit 20 can be manufactured as a single unit, the drug unit 20 differs from the device manufacturer that manufactures the main unit 10. It is also possible for the manufacturer to manufacture the drug unit 20. Therefore, the production of the drug unit 20 can be shared by many drug suppliers, which can contribute to a reduction in manufacturing cost.
- the battery 18 is built in the main unit 10 of the capsule device 1, and the battery 18 supplies power to the internal circuit of the main unit 10.
- the present invention is not limited to such a configuration.
- power supply and control signal transmission / reception are performed by wireless means from outside. It is also conceivable to adopt a configuration in which a wireless power supply unit is provided. With such a configuration, it is possible to obtain exactly the same effects as in the first embodiment.
- positional information about a lesion or the like in a body cavity may be known based on a diagnosis result or the like performed using other means in advance.
- the configuration of the main body unit 10 in the capsule device 1 of the first embodiment described above was introduced into the body cavity, for example, instead of a relatively expensive observation unit such as an imaging unit.
- a predetermined position detecting means for detecting the position of the capsule device 1 may be provided.
- a second embodiment of the present invention described below is an example in which an in-vivo information detecting means (in-vivo sensing unit) for detecting a state inside the body is provided instead of the observing means on the body unit side of the capsule device. It is.
- FIG. 5 is a schematic configuration diagram conceptually showing the arrangement of internal components of the medical capsule device according to the second embodiment of the present invention.
- FIG. 6 is a sectional view taken along line AA of FIG.
- various constituent members such as an in-vivo sensing unit, which is an in-vivo information detecting means for detecting a desired portion in a body cavity, are disposed inside the housing.
- a medicine unit 20A (see also FIG. 6) having a mechanism capable of accommodating and discharging a plurality of kinds of medicines.
- FIG. 5 shows a state in which the main unit 10A and the medicine unit 20A are connected.
- the outer shape is formed so that the whole becomes substantially capsule-shaped.
- an external device including control means for externally controlling the main unit 10A and the like is provided.
- the system includes a control device and the like (not shown).
- the main unit 1OA includes a main unit outer case 11A, which is an outer member that seals the inside of the main unit in a liquid-tight manner, and various constituent members disposed inside the main unit outer case 11A.
- In-vivo information detection consisting of a sensor 8 that functions as an observation unit that can observe the state of the body cavity by detecting the state of the body cavity, and a signal processing unit 16A that is a signal processing unit that processes the output signal from the sensor 8
- a wireless power supply unit 9 that receives power by predetermined wireless means and supplies power to the electrical components of the capsule device 1A, a magnetic force generation unit 19b that performs signal control for generating a magnetic force, and the magnetic force generation unit 19b
- a drug release control means comprising a magnetic force control unit 19a for controlling the drive of the motor, and the circuit board 12A and the wireless power supply unit 9, the magnetic force control unit 19a, and the magnetic force generation unit 19b are electrically connected. It is composed of a flexible printed circuit (FPC) 12a and the like.
- FPC flexible printed circuit
- the main unit outer case 11A is formed of a hard member such as a resin, for example, and covers and protects the internal constituent members of the main unit 10A of the force cell device 1A.
- the sensor 8 is provided with a communication part 8a so that a part thereof can communicate with the outside of the main unit exterior case 11A. This makes it possible to detect a state outside the case 11A and inside the body cavity.
- the communication section 8a is unnecessary depending on the type of the sensor 8 used.
- the communication portion 8a is unnecessary in a detection sensor or the like that uses light or the like.
- a window such as a transparent resin is provided at a predetermined portion of the outer case 11A corresponding to the detection element of the sensor 8. Just fine.
- the sensor 8 for detecting and observing the state inside the body cavity includes: For example, a pH (pH) sensor, a temperature sensor, a pressure sensor, a blood or tumor marker detection sensor, or the like is used.
- the wireless power supply unit 9 has a function equivalent to that of the wireless transmission / reception unit in the first embodiment described above, that is, receives an output signal from the sensor 8 and transmits it to an external control device, or transmits the output signal to the external control device.
- the magnetic force control unit 19a and the magnetic force generation unit 19b constituting the drug release control means are components having functions exactly the same as those of the above-described first embodiment.
- the medicine unit 20A includes a medicine unit outer case 21A formed of a hard member such as a resin and having a space in which the medicine 22 can be filled, and a medicine unit outer case 21A.
- One end of the injection nozzle 24A is formed of a dissolvable film 25 for closing the hole 21a of the medicine unit outer case 21A and making the inside liquid-tight.
- each space can be filled with a different medicine 22 or a plurality of medicines 22 of the same type. It has become.
- Each space is provided with a magnetic attraction portion 23A and an injection nozzle 24A, and a hole 21a is formed in each space.
- Each of the holes 21a is closed by the soluble film 25.
- Each of the magnetic force attracting portions 23 # is arbitrarily operated by drive control of the magnetic force generating portion 19b by the magnetic force control portion 19a of the main unit 10A. Therefore, each of the plurality of drugs 22 can be released at different timings.
- Other configurations are substantially the same as those of the first embodiment. Further, in FIG. 5, constituent members having the same reference numerals as those in the above-described first embodiment have similar functions.
- the operation of the capsule device 1A of the second embodiment configured as described above is substantially the same as that of the above-described first embodiment.
- the in-vivo sensing unit as the in-vivo information detecting means is provided instead of the imaging unit as the observing means of the first embodiment, the operation of the in-vivo sensing unit is mainly performed. Is briefly described below.
- a medicine unit 20A filled with a medicine 22 according to a use to be used is combined with a main unit 10A having a sensor 8 according to the use to be used.
- a capsule device 1A To construct the capsule device 1A.
- the dissolvable film 25 dissolves in the body cavity as in the first embodiment described above, and each hole 21a of the medicine unit outer case 21A is opened. State.
- the sensor 8 moves while detecting the state in the body cavity via the communication portion 8a.
- the output of the sensor 8 is transmitted to the wireless power supply unit 9 via the signal processing unit 16A, and is transmitted to the external control device via this.
- the operator can always know the state in the body cavity.
- the capsule device 1A is monitored while observing the detection result by the sensor 8, and when the capsule device 1A reaches a desired part, the operator performs a predetermined operation of the external control device. Then, a predetermined control signal is transmitted to the magnetic force control unit 19a via the wireless transmission / reception unit of the wireless power supply unit 9 of the main unit 10A.
- a predetermined operation is automatically performed by a signal of the sensing unit power, and a predetermined control signal is transmitted to the magnetic force control unit 19a.
- the magnetic force control unit 19a In response to this, the magnetic force control unit 19a generates a magnetic force from a predetermined portion of the magnetic force generation unit 19b. As a result, the magnetic attraction portion 23A corresponding to the space filled with the desired medicine 22 acts, and the medicine 22 is ejected from the hole 21a to the outside via the ejection nozzle 24A. This As a result, the medicine 22 is attached to a desired site such as a lesion in the body cavity of the subject. If necessary, the same operation is performed for the number of types of the filled medicine 22.
- the capsule device 1A continues to move further due to peristalsis in the body cavity, and is naturally discharged outside the body.
- the internal structure of the medicine unit 20 ⁇ is devised so that a plurality of kinds of medicines 22 can be simultaneously and separately charged, and each medicine 22 can be separately charged at any time. Since it can be ejected to the outside, a single capsule device 1 # can cope with a plurality of types of drugs 22, and can cope with more complicated treatments.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Medical Informatics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Optics & Photonics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Chemical & Material Sciences (AREA)
- Radiology & Medical Imaging (AREA)
- Medicinal Chemistry (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Endoscopes (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04807084A EP1698267A4 (en) | 2003-12-25 | 2004-12-15 | GELULE DEVICE FOR MEDICAL USE |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003431383A JP2005185567A (ja) | 2003-12-25 | 2003-12-25 | 医療用カプセル装置 |
JP2003-431383 | 2003-12-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005063111A1 true WO2005063111A1 (ja) | 2005-07-14 |
Family
ID=34697659
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2004/018725 WO2005063111A1 (ja) | 2003-12-25 | 2004-12-15 | 医療用カプセル装置 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20050143623A1 (ja) |
EP (1) | EP1698267A4 (ja) |
JP (1) | JP2005185567A (ja) |
CN (1) | CN1897867A (ja) |
WO (1) | WO2005063111A1 (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007010997A1 (ja) * | 2005-07-20 | 2007-01-25 | Olympus Medical Systems Corp. | 体腔内導入装置用留置装置および体腔内導入装置留置システム |
JP2008237639A (ja) * | 2007-03-28 | 2008-10-09 | Fujifilm Corp | カプセル内視鏡システム、およびカプセル内視鏡の動作制御方法 |
JP2010504135A (ja) * | 2006-09-25 | 2010-02-12 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | 薬剤送達装置 |
Families Citing this family (91)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030216622A1 (en) * | 2002-04-25 | 2003-11-20 | Gavriel Meron | Device and method for orienting a device in vivo |
US20050137459A1 (en) | 2003-12-17 | 2005-06-23 | Scimed Life Systems, Inc. | Medical device with OLED illumination light source |
US8702597B2 (en) * | 2003-12-31 | 2014-04-22 | Given Imaging Ltd. | Immobilizable in-vivo imager with moveable focusing mechanism |
US7643865B2 (en) * | 2004-06-30 | 2010-01-05 | Given Imaging Ltd. | Autonomous in-vivo device |
US20060149132A1 (en) * | 2004-12-30 | 2006-07-06 | Given Imaging Ltd. | Device and method for in vivo illumination |
JP4512834B2 (ja) * | 2005-03-22 | 2010-07-28 | 国立大学法人大阪大学 | カプセル内視鏡画像表示制御装置 |
US8802183B2 (en) | 2005-04-28 | 2014-08-12 | Proteus Digital Health, Inc. | Communication system with enhanced partial power source and method of manufacturing same |
US8730031B2 (en) | 2005-04-28 | 2014-05-20 | Proteus Digital Health, Inc. | Communication system using an implantable device |
US8912908B2 (en) | 2005-04-28 | 2014-12-16 | Proteus Digital Health, Inc. | Communication system with remote activation |
CN103259027A (zh) | 2005-04-28 | 2013-08-21 | 普罗透斯数字保健公司 | 药物信息系统 |
US8836513B2 (en) | 2006-04-28 | 2014-09-16 | Proteus Digital Health, Inc. | Communication system incorporated in an ingestible product |
US9198608B2 (en) | 2005-04-28 | 2015-12-01 | Proteus Digital Health, Inc. | Communication system incorporated in a container |
US20070260116A1 (en) * | 2005-08-29 | 2007-11-08 | Olympus Corporation And Olympus Medical Systems Corp. | Body-insertable apparatus and receiving apparatus for recognizing remaining power amount |
JP4804831B2 (ja) * | 2005-08-29 | 2011-11-02 | オリンパス株式会社 | 被検体内情報取得システム |
US8547248B2 (en) | 2005-09-01 | 2013-10-01 | Proteus Digital Health, Inc. | Implantable zero-wire communications system |
JP4981316B2 (ja) * | 2005-12-16 | 2012-07-18 | オリンパスメディカルシステムズ株式会社 | 被検体内導入装置 |
DE102006014885A1 (de) * | 2006-03-30 | 2007-10-18 | Siemens Ag | Endoskopische Vorrichtung mit Biochip-Sensor |
EP2013829A4 (en) | 2006-05-02 | 2010-07-07 | Proteus Biomedical Inc | PERSONALIZED THERAPEUTIC REGIMES FOR A PATIENT |
JP4716922B2 (ja) * | 2006-05-23 | 2011-07-06 | オリンパスメディカルシステムズ株式会社 | カプセル型医療装置およびこれを用いた薬剤導入システム |
ATE535057T1 (de) * | 2006-10-17 | 2011-12-15 | Proteus Biomedical Inc | Niederspannungsoszillator für medizinische einrichtungen |
KR101611240B1 (ko) | 2006-10-25 | 2016-04-11 | 프로테우스 디지털 헬스, 인코포레이티드 | 복용 가능한 제어된 활성화 식별자 |
WO2008059728A1 (fr) * | 2006-11-17 | 2008-05-22 | Panasonic Electric Works Co., Ltd. | Dispositif de type capsule pour administrer un médicament |
US8718193B2 (en) | 2006-11-20 | 2014-05-06 | Proteus Digital Health, Inc. | Active signal processing personal health signal receivers |
EP2094158B1 (en) * | 2006-11-21 | 2018-05-02 | STOCO 10 GmbH | Ingestible electronic capsule and in vivo drug delivery or diagnostic system |
WO2008095183A2 (en) | 2007-02-01 | 2008-08-07 | Proteus Biomedical, Inc. | Ingestible event marker systems |
US8956288B2 (en) * | 2007-02-14 | 2015-02-17 | Proteus Digital Health, Inc. | In-body power source having high surface area electrode |
JP5330222B2 (ja) | 2007-03-01 | 2013-10-30 | オリンパスメディカルシステムズ株式会社 | 管腔通過確認装置、管腔通過確認方法、および管腔通過確認装置の製造方法 |
US8932221B2 (en) | 2007-03-09 | 2015-01-13 | Proteus Digital Health, Inc. | In-body device having a multi-directional transmitter |
EP2063771A1 (en) | 2007-03-09 | 2009-06-03 | Proteus Biomedical, Inc. | In-body device having a deployable antenna |
US8115618B2 (en) | 2007-05-24 | 2012-02-14 | Proteus Biomedical, Inc. | RFID antenna for in-body device |
CN101342067B (zh) * | 2007-07-11 | 2010-08-25 | 重庆特奥科技有限公司 | 医用工具胶囊 |
US10441766B2 (en) | 2007-08-08 | 2019-10-15 | Given Imaging Ltd. | Method for clearing a body lumen environment |
US20110230714A1 (en) * | 2007-08-08 | 2011-09-22 | Given Imaging Ltd. | Method for clearing a body lumen environment |
PT2192946T (pt) | 2007-09-25 | 2022-11-17 | Otsuka Pharma Co Ltd | Dispositivo no corpo com amplificação de sinal dipolo virtual |
WO2009070773A1 (en) | 2007-11-27 | 2009-06-04 | Proteus Biomedical, Inc. | Transbody communication systems employing communication channels |
ES2636844T3 (es) | 2008-03-05 | 2017-10-09 | Proteus Biomedical, Inc. | Sistemas y marcadores de eventos ingeribles de comunicación multimodo, y métodos para usarlos |
CN104473619A (zh) | 2008-04-18 | 2015-04-01 | 西门子公司 | 检测特定细菌的方法以及一种胶囊内窥镜的应用 |
EP3427660A1 (en) | 2008-07-08 | 2019-01-16 | Proteus Digital Health, Inc. | Ingestible event marker data framework |
WO2010019778A2 (en) | 2008-08-13 | 2010-02-18 | Proteus Biomedical, Inc. | Ingestible circuitry |
KR101192690B1 (ko) * | 2008-11-13 | 2012-10-19 | 프로테우스 디지털 헬스, 인코포레이티드 | 섭취 가능한 치료 활성화 시스템, 치료 장치 및 방법 |
EP2358270A4 (en) * | 2008-12-11 | 2014-08-13 | Proteus Digital Health Inc | EVALUATION OF STOMACH DARM FUNCTIONS USING PORTABLE ELECTRIC VISCEROGRAPHY SYSTEMS AND METHOD OF USE THEREOF |
US9659423B2 (en) | 2008-12-15 | 2017-05-23 | Proteus Digital Health, Inc. | Personal authentication apparatus system and method |
US9439566B2 (en) | 2008-12-15 | 2016-09-13 | Proteus Digital Health, Inc. | Re-wearable wireless device |
TWI503101B (zh) | 2008-12-15 | 2015-10-11 | Proteus Digital Health Inc | 與身體有關的接收器及其方法 |
KR20110104079A (ko) | 2009-01-06 | 2011-09-21 | 프로테우스 바이오메디컬, 인코포레이티드 | 약제학적 투여량 전달 시스템 |
CN102341031A (zh) | 2009-01-06 | 2012-02-01 | 普罗秋斯生物医学公司 | 摄取相关的生物反馈和个人化医学治疗方法和系统 |
US8540664B2 (en) | 2009-03-25 | 2013-09-24 | Proteus Digital Health, Inc. | Probablistic pharmacokinetic and pharmacodynamic modeling |
CN102378637B (zh) * | 2009-04-07 | 2014-12-24 | 皇家飞利浦电子股份有限公司 | 无阀给药装置 |
NZ619375A (en) | 2009-04-28 | 2015-03-27 | Proteus Digital Health Inc | Highly reliable ingestible event markers and methods for using the same |
US9149423B2 (en) | 2009-05-12 | 2015-10-06 | Proteus Digital Health, Inc. | Ingestible event markers comprising an ingestible component |
EP2394565B1 (en) | 2009-08-07 | 2013-05-01 | Olympus Medical Systems Corp. | Medical system |
JP2013501568A (ja) * | 2009-08-12 | 2013-01-17 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | 薬品送出装置のための医薬貯槽 |
EP2467707A4 (en) | 2009-08-21 | 2014-12-17 | Proteus Digital Health Inc | DEVICE AND METHOD FOR MEASURING BIOLOGICAL PARAMETERS |
JP5992330B2 (ja) * | 2009-09-29 | 2016-09-14 | メディメトリクス ペルソナリズド ドルグ デリヴェリー ベー ヴェ | 物質を投与するための子宮内電子カプセル |
TWI517050B (zh) | 2009-11-04 | 2016-01-11 | 普羅托斯數位健康公司 | 供應鏈管理之系統 |
UA109424C2 (uk) | 2009-12-02 | 2015-08-25 | Фармацевтичний продукт, фармацевтична таблетка з електронним маркером і спосіб виготовлення фармацевтичної таблетки | |
JP5841951B2 (ja) | 2010-02-01 | 2016-01-13 | プロテウス デジタル ヘルス, インコーポレイテッド | データ収集システム |
WO2011127252A2 (en) | 2010-04-07 | 2011-10-13 | Proteus Biomedical, Inc. | Miniature ingestible device |
TWI557672B (zh) | 2010-05-19 | 2016-11-11 | 波提亞斯數位康健公司 | 用於從製造商跟蹤藥物直到患者之電腦系統及電腦實施之方法、用於確認將藥物給予患者的設備及方法、患者介面裝置 |
EP2642983A4 (en) | 2010-11-22 | 2014-03-12 | Proteus Digital Health Inc | DEVICE INGREABLE WITH PHARMACEUTICAL PRODUCT |
CN102090876B (zh) * | 2011-03-04 | 2012-10-17 | 上海交通大学 | 基于无线供能的体外磁控制药物释放胶囊系统 |
US9439599B2 (en) | 2011-03-11 | 2016-09-13 | Proteus Digital Health, Inc. | Wearable personal body associated device with various physical configurations |
US9756874B2 (en) | 2011-07-11 | 2017-09-12 | Proteus Digital Health, Inc. | Masticable ingestible product and communication system therefor |
WO2015112603A1 (en) | 2014-01-21 | 2015-07-30 | Proteus Digital Health, Inc. | Masticable ingestible product and communication system therefor |
MX340001B (es) | 2011-07-21 | 2016-06-20 | Proteus Digital Health Inc | Dispositivo, sistema y método de comunicación móvil. |
US8816814B2 (en) | 2011-08-16 | 2014-08-26 | Elwha Llc | Systematic distillation of status data responsive to whether or not a wireless signal has been received and relating to regimen compliance |
US9235683B2 (en) | 2011-11-09 | 2016-01-12 | Proteus Digital Health, Inc. | Apparatus, system, and method for managing adherence to a regimen |
TWI458458B (zh) * | 2012-02-24 | 2014-11-01 | Crystalvue Medical Corp | 膠囊內視鏡裝置 |
CN104135988A (zh) * | 2012-02-29 | 2014-11-05 | 索尼公司 | 医疗装置、医疗系统和程序 |
JP2015534539A (ja) | 2012-07-23 | 2015-12-03 | プロテウス デジタル ヘルス, インコーポレイテッド | 摂取可能構成要素を備える摂取可能事象マーカーを製造するための技法 |
JP5869736B2 (ja) | 2012-10-18 | 2016-02-24 | プロテウス デジタル ヘルス, インコーポレイテッド | 通信デバイス用の電源において電力消失およびブロードキャスト電力を適応的に最適化するための装置、システム、および方法 |
US11149123B2 (en) | 2013-01-29 | 2021-10-19 | Otsuka Pharmaceutical Co., Ltd. | Highly-swellable polymeric films and compositions comprising the same |
US11744481B2 (en) | 2013-03-15 | 2023-09-05 | Otsuka Pharmaceutical Co., Ltd. | System, apparatus and methods for data collection and assessing outcomes |
WO2014151929A1 (en) | 2013-03-15 | 2014-09-25 | Proteus Digital Health, Inc. | Personal authentication apparatus system and method |
WO2014144738A1 (en) | 2013-03-15 | 2014-09-18 | Proteus Digital Health, Inc. | Metal detector apparatus, system, and method |
US9796576B2 (en) | 2013-08-30 | 2017-10-24 | Proteus Digital Health, Inc. | Container with electronically controlled interlock |
CA2965941C (en) | 2013-09-20 | 2020-01-28 | Proteus Digital Health, Inc. | Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping |
WO2015044722A1 (en) | 2013-09-24 | 2015-04-02 | Proteus Digital Health, Inc. | Method and apparatus for use with received electromagnetic signal at a frequency not known exactly in advance |
US10084880B2 (en) | 2013-11-04 | 2018-09-25 | Proteus Digital Health, Inc. | Social media networking based on physiologic information |
US9750923B2 (en) * | 2014-11-19 | 2017-09-05 | Velóce Corporation | Wireless communications system integrating electronics into orally ingestible products for controlled release of active ingredients |
US11051543B2 (en) | 2015-07-21 | 2021-07-06 | Otsuka Pharmaceutical Co. Ltd. | Alginate on adhesive bilayer laminate film |
CN105559737A (zh) * | 2015-12-21 | 2016-05-11 | 中国科学院合肥物质科学研究院 | 一种胶囊内窥镜 |
US10187121B2 (en) | 2016-07-22 | 2019-01-22 | Proteus Digital Health, Inc. | Electromagnetic sensing and detection of ingestible event markers |
TWI735689B (zh) | 2016-10-26 | 2021-08-11 | 日商大塚製藥股份有限公司 | 製造含有可攝食性事件標記之膠囊之方法 |
CN106618455A (zh) * | 2016-11-28 | 2017-05-10 | 电子科技大学 | 一种具有定点施药功能的胶囊内窥镜系统 |
AU2017402709B2 (en) | 2017-03-07 | 2023-08-17 | University Of Southampton | Intra-uterine monitoring system |
CN107497039B (zh) * | 2017-10-18 | 2020-04-17 | 河南科技大学第一附属医院 | 肿瘤内科给药装置 |
CN108720794B (zh) * | 2018-06-08 | 2023-09-08 | 苏州市启献智能科技有限公司 | 一种电致动安全解体胶囊胃镜 |
USD891632S1 (en) * | 2018-10-08 | 2020-07-28 | Tidhar Dari Shalon | Gastrointestinal sampling device |
US12064090B2 (en) | 2021-10-18 | 2024-08-20 | Omnivision Technologies, Inc. | Endoscope tip assembly using cavity interposer to allow coplanar camera and LEDs |
US11943525B2 (en) | 2022-02-17 | 2024-03-26 | Omnivision Technologies, Inc. | Electronic camera module with integral LED and light-pipe illuminator |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03146031A (ja) * | 1989-11-01 | 1991-06-21 | Olympus Optical Co Ltd | 体内カプセル |
JPH0564661A (ja) * | 1991-09-09 | 1993-03-19 | Olympus Optical Co Ltd | 体腔内挿入具 |
JPH06114036A (ja) * | 1992-10-05 | 1994-04-26 | Olympus Optical Co Ltd | 医療用カプセル |
JPH08502905A (ja) * | 1992-09-01 | 1996-04-02 | エドウィン エル アデアー, | 分離可能の使い捨て管組立体を有する滅菌可能の内視鏡 |
US5558640A (en) * | 1994-03-17 | 1996-09-24 | Siemens Aktiengesellschaft | System for infusion of medicine into the body of a patient |
JP2000507124A (ja) * | 1996-03-01 | 2000-06-13 | グルント,カール・エルンスト | 一種以上の液体を内視鏡的に注入する方法及び装置 |
JP2003135387A (ja) * | 2001-10-30 | 2003-05-13 | Olympus Optical Co Ltd | カプセル型医療装置 |
JP2003524448A (ja) * | 1998-10-22 | 2003-08-19 | ギブン・イメージング・リミテツド | 標的部位に装置を送り出す方法 |
JP2003325438A (ja) * | 2002-05-10 | 2003-11-18 | Olympus Optical Co Ltd | カプセル型医療装置 |
JP2004329292A (ja) * | 2003-04-30 | 2004-11-25 | Shimadzu Corp | 小型撮影装置 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5318557A (en) * | 1992-07-13 | 1994-06-07 | Elan Medical Technologies Limited | Medication administering device |
EP1578246B1 (en) * | 2001-07-12 | 2014-09-03 | Given Imaging Ltd. | Device for examining a body lumen |
JP4744026B2 (ja) * | 2001-07-30 | 2011-08-10 | オリンパス株式会社 | カプセル内視鏡およびカプセル内視鏡システム |
US6951536B2 (en) * | 2001-07-30 | 2005-10-04 | Olympus Corporation | Capsule-type medical device and medical system |
-
2003
- 2003-12-25 JP JP2003431383A patent/JP2005185567A/ja active Pending
-
2004
- 2004-12-15 US US11/013,267 patent/US20050143623A1/en not_active Abandoned
- 2004-12-15 CN CNA2004800390168A patent/CN1897867A/zh active Pending
- 2004-12-15 EP EP04807084A patent/EP1698267A4/en not_active Withdrawn
- 2004-12-15 WO PCT/JP2004/018725 patent/WO2005063111A1/ja not_active Application Discontinuation
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03146031A (ja) * | 1989-11-01 | 1991-06-21 | Olympus Optical Co Ltd | 体内カプセル |
JPH0564661A (ja) * | 1991-09-09 | 1993-03-19 | Olympus Optical Co Ltd | 体腔内挿入具 |
JPH08502905A (ja) * | 1992-09-01 | 1996-04-02 | エドウィン エル アデアー, | 分離可能の使い捨て管組立体を有する滅菌可能の内視鏡 |
JPH06114036A (ja) * | 1992-10-05 | 1994-04-26 | Olympus Optical Co Ltd | 医療用カプセル |
US5558640A (en) * | 1994-03-17 | 1996-09-24 | Siemens Aktiengesellschaft | System for infusion of medicine into the body of a patient |
JP2000507124A (ja) * | 1996-03-01 | 2000-06-13 | グルント,カール・エルンスト | 一種以上の液体を内視鏡的に注入する方法及び装置 |
JP2003524448A (ja) * | 1998-10-22 | 2003-08-19 | ギブン・イメージング・リミテツド | 標的部位に装置を送り出す方法 |
JP2003135387A (ja) * | 2001-10-30 | 2003-05-13 | Olympus Optical Co Ltd | カプセル型医療装置 |
JP2003325438A (ja) * | 2002-05-10 | 2003-11-18 | Olympus Optical Co Ltd | カプセル型医療装置 |
JP2004329292A (ja) * | 2003-04-30 | 2004-11-25 | Shimadzu Corp | 小型撮影装置 |
Non-Patent Citations (1)
Title |
---|
See also references of EP1698267A4 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007010997A1 (ja) * | 2005-07-20 | 2007-01-25 | Olympus Medical Systems Corp. | 体腔内導入装置用留置装置および体腔内導入装置留置システム |
JP2010504135A (ja) * | 2006-09-25 | 2010-02-12 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | 薬剤送達装置 |
US9550050B2 (en) | 2006-09-25 | 2017-01-24 | MEDIMETRICS Personalized Drug Delivery B.V. | Medicament delivery apparatus |
JP2008237639A (ja) * | 2007-03-28 | 2008-10-09 | Fujifilm Corp | カプセル内視鏡システム、およびカプセル内視鏡の動作制御方法 |
Also Published As
Publication number | Publication date |
---|---|
EP1698267A1 (en) | 2006-09-06 |
JP2005185567A (ja) | 2005-07-14 |
CN1897867A (zh) | 2007-01-17 |
EP1698267A4 (en) | 2009-01-14 |
US20050143623A1 (en) | 2005-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005063111A1 (ja) | 医療用カプセル装置 | |
JP4578740B2 (ja) | カプセル型医療装置 | |
JP4329394B2 (ja) | 小型撮影装置 | |
JP4643089B2 (ja) | カプセル型医療装置 | |
JP4744026B2 (ja) | カプセル内視鏡およびカプセル内視鏡システム | |
JP4520126B2 (ja) | カプセル型医療装置システム | |
US7770725B2 (en) | Capsule endoscope storage case | |
WO2005023102A1 (ja) | 被検体内導入装置および無線型被検体内情報取得システム | |
WO2007128084A2 (en) | The controllable microcapsule type robot-endoscope | |
US20070249900A1 (en) | In vivo device with balloon stabilizer and valve | |
WO2005011481A1 (ja) | カプセル内視鏡 | |
US10588490B2 (en) | Hand-operated endoscope for medical purposes | |
JP2003325438A (ja) | カプセル型医療装置 | |
JP4323276B2 (ja) | カプセル型医療装置収納具 | |
WO2006073041A1 (ja) | カプセル型内視鏡の収容ケース | |
WO2005087079A1 (ja) | 被検体内導入装置 | |
JP4575260B2 (ja) | 被検体内導入装置 | |
WO2007029814A1 (ja) | カプセル型内視鏡用の光学窓部材 | |
JP2007021039A (ja) | 体腔内導入装置および体腔内導入装置留置システム | |
JP2009006154A (ja) | カプセル型医療装置 | |
JP2003135387A (ja) | カプセル型医療装置 | |
JP4700409B2 (ja) | 医用カプセル | |
JP4772384B2 (ja) | 医用カプセル | |
JP4632734B2 (ja) | カプセル型内視鏡用電源スターター | |
JP2006325874A (ja) | カプセル超音波内視鏡、及びカプセル超音波内視鏡装置 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200480039016.8 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DPEN | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2004807084 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: DE |
|
WWP | Wipo information: published in national office |
Ref document number: 2004807084 Country of ref document: EP |